Insider Selling: ASP Isotopes (NASDAQ:ASPI) CFO Sells $145,218.72 in Stock

ASP Isotopes Inc. (NASDAQ:ASPI) CFO Heather Kiessling sold 23,124 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $6.28, for a total transaction of $145,218.72. Following the transaction, the chief financial officer directly owned 1,526,252 shares in the company, valued at approximately $9,584,862.56. The trade was a 1.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Heather Kiessling also recently made the following trade(s):

• On Wednesday, April 15th, Heather Kiessling sold 23,124 shares of ASP Isotopes stock. The stock was sold at an average price of $5.48, for a total transaction of $126,719.52.

ASP Isotopes Stock Performance

Shares of NASDAQ:ASPI opened at $5.63 on Friday. The company has a 50 day moving average of $6.26 and a 200-day moving average of $5.90. The company has a current ratio of 4.39, a quick ratio of 4.37 and a debt-to-equity ratio of 0.69. The firm has a market cap of $708.82 million, a P/E ratio of -2.71 and a beta of 3.51. ASP Isotopes Inc. has a twelve month low of $3.92 and a twelve month high of $14.49.

ASP Isotopes (NASDAQ:ASPI) last released its earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.06. ASP Isotopes had a negative return on equity of 112.46% and a negative net margin of 644.40%.The firm had revenue of $8.36 million during the quarter, compared to the consensus estimate of $3.68 million.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. Canaccord Genuity Group reaffirmed a “buy” rating and set a $11.00 price objective on shares of ASP Isotopes in a research report on Tuesday, April 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Wednesday, June 24th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $13.00.

Institutional Investors Weigh In On ASP Isotopes

Several hedge funds have recently modified their holdings of the business. Encompass Capital Advisors LLC bought a new position in shares of ASP Isotopes during the 1st quarter worth about $30,551,000. Alyeska Investment Group L.P. increased its stake in ASP Isotopes by 73.4% in the fourth quarter. Alyeska Investment Group L.P. now owns 4,895,546 shares of the company’s stock valued at $26,191,000 after acquiring an additional 2,072,851 shares during the period. UBS Group AG raised its position in ASP Isotopes by 150.3% in the fourth quarter. UBS Group AG now owns 2,406,457 shares of the company’s stock worth $12,875,000 after purchasing an additional 1,445,165 shares in the last quarter. Marshall Wace LLP raised its position in ASP Isotopes by 3,669.1% in the third quarter. Marshall Wace LLP now owns 1,279,121 shares of the company’s stock worth $12,305,000 after purchasing an additional 1,245,184 shares in the last quarter. Finally, Vanguard Group Inc. lifted its stake in ASP Isotopes by 37.9% during the third quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company’s stock worth $43,451,000 after purchasing an additional 1,241,024 shares during the period. 16.80% of the stock is owned by institutional investors.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.